Vitamin D3 supplementation for chronic pain relief in hemodialysis patients
Official title: Effects of Multiple Mega-dose of Vitamin D3 Supplementation on Ameliorating Moderate to Severe Chronic Pain in Hemodialysis Patients
Run by Taipei Medical University Hospital · NCT05667090 · Data updated 2026-11-12
This study is testing if high doses of vitamin D3 can help reduce chronic pain in patients on hemodialysis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Taipei Medical University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | March 15, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2027 |
| Registry record updated | March 30, 2023 |
| Trial ID | NCT05667090 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are hemodialysis patients aged 20 and older with chronic pain and elevated parathyroid hormone levels.
✕Probably not a fit
Patients with chronic liver disease, sarcoidosis, or those participating in other clinical trials may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of high-dose vitamin D3 supplementation on chronic pain in patients undergoing hemodialysis. It is a single-center, double-blind, randomized control trial involving 120 participants who will receive either 576,000 IU of vitamin D3 weekly for four weeks or a placebo. The study will assess pain severity using the Visual Analogue Scale (VAS) and measure various laboratory parameters, including parathyroid hormone levels and vitamin D status. The goal is to determine if vitamin D3 can alleviate chronic pain associated with elevated parathyroid hormone levels in this patient population.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce chronic pain in hemodialysis patients, improving their quality of life.
How similar studies have gone: While there is limited research specifically on mega-dose vitamin D for chronic pain in hemodialysis patients, vitamin D supplementation has shown promise in other chronic pain conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Haemodialysis subject ≥ 20 years old 2. iPTH \> 250 pg/mL 3. Chronic pain with visual analogue scale (VAS) score ≥ 4 4. Voluntary to check serum 25(OH)D levels two times by his/her own payment during the study 5. Sign the informed consent Exclusion Criteria: 1. Used to participate in other clinical trials 2. Chronic liver disease 3. Sarcoidosis or multiple myeloma
Where it's running
-
Taipei Medical University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Hsien-Tsung Lu, MD, PhD
- Email: lu7788@tmu.edu.tw
- Phone: +886 2-27372181
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
Flurpiridaz F-18 PET/CT to Find Parathyroid Adenomas
This study tests whether Flurpiridaz F-18 PET/CT can better detect abnormal parathyroid glands in adults with primary hyperparathyroidism before surgery.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.